Company Filing History:
1 out of 3 
1 out of 2 
1 out of 1 Years Active: 2017
Title: Roman Szczesny: Innovator in Cancer Treatment
Introduction
Roman Szczesny is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the development of therapeutic agents that target specific cancer mutations.
Latest Patents
Szczesny holds a patent for a method for the selection of hDIS3 PIN domain inhibitors and their use in cancer treatment. The patent describes a method for screening hDIS3 PIN domain inhibitors, along with the yeast strain and cell line utilized in these methods. This invention is particularly relevant for treating cancers with mutations in the hDIS3 RNB domain, especially multiple myeloma. Additionally, it includes a composition comprising a new therapeutic agent, the hDIS3 PIN domain inhibitor, and a method for inducing synthetic lethality in cancer cells.
Career Highlights
Throughout his career, Roman Szczesny has worked with prominent organizations such as the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and Oncoarendi Therapeutics Sp. z o.o. His research has been instrumental in advancing the understanding of cancer treatment methodologies.
Collaborations
Szczesny has collaborated with notable colleagues, including Andrzej Dziembowski and Rafal Tomecki. These partnerships have contributed to the success of his research and the development of innovative cancer therapies.
Conclusion
Roman Szczesny's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patented methods and collaborations highlight his commitment to advancing therapeutic options for patients.